SCHEMBL8836205

SCHEMBL8836205

Cc1cnccc1-c1c(-c2ccc(F)cc2)nn2cccnc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.57
MAPK14 Q16539 8/20 0.53
EGFR P00533 1/20 0.47
RAF1 P04049 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
GSK3B P49841 1/20 0.47
KCNQ3 O43525 2/20 0.43
KCNQ2 O43526 2/20 0.43
CYP17A1 P05093 5/20 0.43
CYP1A2 P05177 3/20 0.43
CSNK1A1 P48729 1/20 0.43
CSNK1D P48730 1/20 0.43
CSNK1E P49674 1/20 0.43
MAPK13 O15264 1/20 0.42
GCGR P47871 1/20 0.42
MAPK12 P53778 1/20 0.42
MAPK11 Q15759 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8836681 0.81 PTGS2 (0.70) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836442 0.81 PTGS2 (0.70) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836182 0.81 PTGS2 (0.62) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836423 0.78 PTGS2 (0.59) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836696 0.76 PTGS2 (0.62) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836680 0.76 PTGS2 (0.63) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL8836452 0.73 PTGS2 (0.62) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL14844728 0.72 PTGS2 (0.56) PTGS2MAPK14EGFRRAF1ADORA3
SCHEMBL23557736 0.70 MAPK14 (0.52) MAPK14CYP17A1CSNK1DCSNK1EMAPK13
SCHEMBL5388438 0.69 MAPK14 (1.00) PTGS2MAPK14EGFRRAF1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624931-A Pyrazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-29 US disclosed
US-5478827-A Inhibits Interleukin-1 and tumor necrosis factor production FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-12-26 US disclosed
US-5356897-A Inhibit the production of Interleukin-1 and tumor necrosis factor; administering for treatment of chronic inflammatory diseases, autoimmune diseases and sepsis-induced organ injury FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-10-18 US disclosed
EP-0531901-A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed